Psychotropic Medication Documentation and PRN Behavior Monitoring Deficiencies Survey review found that several residents had psychotropic medications ordered without documented physician rationale, resident-specific target behaviors, or individualized non-pharmacological interventions. Generic behavior-monitoring orders were used instead of approaches tied to each resident’s history, interests, and identified behaviors, and one resident’s PRN antipsychotic was administered multiple times without documentation of attempted non-pharmacological interventions before use. The EMR also showed notes of stability or no unwanted behaviors for some residents, yet the records still lacked rationale supporting continued psychotropic treatment.
A resident with dementia and bipolar disorder was given olanzapine, but the pharmacist and physician recommended a GDR without documentation that the resident’s representative was informed before the change was implemented. Another resident with Alzheimer’s disease, depression, insomnia, and PTSD had repeated agitation and exit-seeking while receiving multiple psychotropic medications, but the IDT review of sertraline was not clearly documented and the care plan lacked resident-specific non-pharmacological interventions or clear behavior monitoring details.
Failure to Reevaluate PRN Psychotropic Medication: A resident with vascular dementia, restlessness, agitation, and severe cognitive impairment received PRN lorazepam under an order written for 90 days. The record showed the PRN psychotropic was not reevaluated after the 14-day limit and no physician rationale was documented to justify continued use beyond that period, despite doses being administered during the month.
A resident with mood disorder, anxiety, vascular dementia, and depression was prescribed sertraline, but the EMR had no documentation of behavior monitoring, side effect monitoring, or effectiveness monitoring. Staff reported the resident yelled out, moved tables, hit staff, and slept most of the time, yet the resident was not added to the alert charting binder and had no care plan for psychotropic monitoring.
Unreviewed psychotropic medication use without documented GDR consideration. A resident with dementia, cognitive impairment, wandering, and prior behaviors remained on Seroquel for dementia with behaviors, but the record did not show quarterly IDT review of continued need or GDR consideration. Observations showed the resident sleeping in bed while activities were offered to others, and the chart lacked documentation addressing PHQ-9 findings or follow-up for mood concerns. MAR/TAR review showed no documented behaviors during the review period, yet the psychotropic medication continued without documented IDT justification.
A resident with Lewy body dementia, parkinsonism, and anxiety received PRN lorazepam and Seroquel without the facility enforcing the 14‑day limit for PRN psychotropic orders or obtaining documented physician reevaluation and rationale for continuation beyond that period. Pharmacy reviews had recommended 14‑day stop dates and behavior tracking for psychotropics, but these were not timely implemented, and the EMR lacked consistent behavior and side‑effect monitoring orders or documentation for the resident’s lorazepam and Seroquel. Nursing and leadership staff reported that they typically monitor behaviors and side effects for psychotropic use and understood that PRN psychotropics should not exceed 14 days, yet the DON confirmed that behavior and side‑effect monitoring orders were missing for this resident and that new medication orders were not being reviewed daily.
A resident with dementia, COPD, pneumonia, and mild depression was prescribed an antidepressant, an antianxiety medication, and an antipsychotic, but the record did not show documented behaviors to justify the antipsychotic use. The care plan lacked specific target behaviors, the MARs did not include mood or behavior tracking or side effect monitoring for the antipsychotic and antianxiety meds, and the chart did not contain consent documentation for the psychotropic medications.
A resident with dementia, depression, and anxiety was given sertraline and escalating doses of olanzapine, but the chart did not show documented behavior increases or worsening condition to justify the changes. The care plans and behavior monitoring were not updated to match the dose increases, the TAR had no documented behaviors, and psychiatrist notes repeatedly described the resident as calm, cooperative, and at baseline. Staff interviews also described limited behavioral concerns, and the facility could not provide documentation supporting the psychotropic increases.
A resident with Alzheimer's disease, anxiety, and depression received a PRN lorazepam order for agitation/anxiety without a stop date. The EMR lacked documentation of non-pharmacological interventions, a physician rationale for continuing the PRN psychotropic beyond the 14-day limit, and monitoring of behaviors or medication effectiveness, and there was no care plan addressing the medication.
PRN lorazepam was ordered for a resident with dementia, anxiety, and depression without a 14-day limit and without documented physician rationale for continued use beyond that timeframe. The resident remained on the PRN antianxiety medication, and the MAR showed a dose was administered, but the record contained no note showing the order was reevaluated or justified as required; the DON was unaware of the 14-day rule, and the pharmacist confirmed no rationale was documented.
Self-audit
Pick a level of detail and, optionally, what to focus on — then generate a survey-ready checklist distilled from the most recent citations.
Beta · AI-generated — for reference only, not professional advice. Verify against current CMS guidance before relying on it. Assisto accepts no responsibility for how this checklist is used.
Citations used to create this checklist
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release June 24, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.